Showing 1 - 17 results of 17 for search 'Robert P. Frantz', query time: 0.05s
Refine Results
-
1
-
2
-
3
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository by Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Andrew Frick, Lisa Lancaster, Scott Milligan, Ronald Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan
Published 2023-07-01
Article -
4
Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study by Kathryn T. delValle, Michael J. Krowka, Carrie A. Schinstock, Karl A. Nath, Charles D. Burger, Yogesh N. Reddy, Robert P. Frantz, Y. S. Prakash, Hilary M. DuBrock
Published 2024-01-01
Article -
5
Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy by Vidhu Anand, Megan K. Covington, Ushasi Saraswati, Christopher G. Scott, Alexander T. Lee, Robert P. Frantz, Nandan S. Anavekar, Jeffrey B. Geske, Adelaide M. Arruda-Olson, Kyle W. Klarich
Published 2024-01-01
Article -
6
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH) by Nicholas S. Hill, Jeremy P. Feldman, Sandeep Sahay, Raymond L. Benza, Ioana R. Preston, David Badesch, Robert P. Frantz, Savan Patel, Ashley Galloway, Todd M. Bull, the INSPIRE study investigators
Published 2022-07-01
Article -
7
Mate-pair sequencing identifies a cryptic mutation in hereditary pulmonary arterial hypertension by Sarah J. Chalmers, Stephen J. Murphy, Laura L. Thompson, Nicole L. Hoppman, James B. Smadbeck, Jessica R. Balcom, Faye R. Harris, Robert P. Frantz, George Vasmatzis, Mark E. Wylam
Published 2020-06-01
Article -
8
Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry by Kevin Y. Chang, Sue Duval, David B. Badesch, Todd M. Bull, Murali M. Chakinala, Teresa De Marco, Robert P. Frantz, Anna Hemnes, Stephen C. Mathai, Erika Berman Rosenzweig, John J. Ryan, Thenappan Thenappan
Published 2022-05-01
Article -
9
Using PAH‐SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease by Morgan E. Bailey, Louise Durst, Hector R. Cajigas, Garvan C. Kane, Michael J. Krowka, Sudhir S. Kushwaha, Robert B. McCully, Joseph G. Murphy, Yogesh N. Reddy, Robert P. Frantz, Hilary M. DuBrock
Published 2024-01-01
Article -
10
Safety of macitentan for the treatment of pulmonary hypertension: Real‐world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS) by Vallerie V. McLaughlin, Richard Channick, Nick H. Kim, Robert P. Frantz, John W. McConnell, Lana Melendres‐Groves, Chad Miller, Ashwin Ravichandran, Josanna Rodriguez‐Lopez, Monika Brand, Sandrine Leroy, Graham Wetherill, Kelly M. Chin
Published 2022-10-01
Article -
11
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study by Robert P. Frantz, Jane A. Leopold, Paul M. Hassoun, Anna R. Hemnes, Evelyn M. Horn, Stephen C. Mathai, Franz P. Rischard, A. Brett Larive, W.h. Wilson Tang, Margaret M. Park, Nicholas S. Hill, Erika B. Rosenzweig
Published 2023-01-01
Article -
12
The feasibility and value of assessing patient‐reported outcomes in pulmonary arterial hypertension by Hilary M. DuBrock, Yogesh N. Reddy, Louise A. Durst, Darrell R. Schroeder, Grace Park, Hector R. Cajigas, Garvan C. Kane, Sudhir S. Kushwaha, Robert B. McCully, Joseph G. Murphy, Vidhu Anand, Michael J. Krowka, Robert P. Frantz
Published 2022-10-01
Article -
13
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trial by Mardi Gomberg-Maitland, Robert C. Bourge, Shelley M. Shapiro, James H. Tarver, Dianne L. Zwicke, Jeremy P. Feldman, Murali M. Chakinala, Robert P. Frantz, Fernando Torres, Remzi Bag, Jeffrey A. Murphy, Amy A. Lautenbach, Marty Morris, Leigh Peterson, Aaron B. Waxman
Published 2019-11-01
Article -
14
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension by Robert P. Frantz, Raymond L. Benza, Richard N. Channick, Kelly Chin, Luke S. Howard, Vallerie V. McLaughlin, Olivier Sitbon, Roham T. Zamanian, Anna R. Hemnes, Matt Cravets, Jean‐Marie Bruey, Robert Roscigno, David Mottola, Erin Elman, Lawrence S. Zisman, Hossein‐Ardeschir Ghofrani
Published 2021-10-01
Article -
15
SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation by Robert P. Frantz, Shashank S. Desai, Gregory Ewald, Veronica Franco, Antoine Hage, Evelyn M. Horn, Shane J. LaRue, Michael A. Mathier, Stacy Mandras, Myung H. Park, Ashwin K. Ravichandran, Joel D. Schilling, I‐wen Wang, Ronald Zolty, Gabriela Gomez Rendon, Mark A. Rocco, Mona Selej, Carol Zhao, J. Eduardo Rame
Published 2024-10-01
Article -
16
Health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmona... by Jasleen Minhas, Sai Prasanna Narasimmal, Todd M. Bull, Teresa De Marco, John Wesley McConnell, Matthew R. Lammi, Thenappan Thenappan, Jeremy P. Feldman, Jeffrey S. Sager, David B. Badesch, John J. Ryan, Daniel C. Grinnan, Dianne Zwicke, Evelyn M. Horn, Jean M. Elwing, John E. Moss, Michael Eggert, Oksana A. Shlobin, Robert P. Frantz, Sonja D. Bartolome, Stephen C. Mathai, Sula Mazimba, Steven C. Pugliese, Nadine Al‐Naamani, PHAR investigators
Published 2021-10-01
Article -
17
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Associ... by Hilary M. DuBrock, Charles D. Burger, Sonja D. Bartolome, Jeremy P. Feldman, David D. Ivy, Erika B. Rosenzweig, Jeffrey S. Sager, Kenneth W. Presberg, Stephen C. Mathai, Matthew R. Lammi, James R. Klinger, Michael Eggert, Teresa De Marco, Jean M. Elwing, David Badesch, Todd M. Bull, Linda M. Cadaret, Gautam Ramani, Thenappan Thenappan, H. James Ford, Nadine Al‐Naamani, Marc A. Simon, Sula Mazimba, James R. Runo, Murali Chakinala, Evelyn M. Horn, John J. Ryan, Robert P. Frantz, Michael J. Krowka, PHAR Investigators
Published 2022-10-01
Article